Loading…
Sellas Life Sciences Group Inc. surged after the drug developer reported positive late-stage trial results for an experimental cancer vaccine to treat an aggressive form of blood cancer.
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.